Abstract. The present study was conducted to compare the effects of exogenous follistatin and activin A on liver regeneration in 90% hepatectomized rats. Intraportal administration of follistatin markedly accelerated liver regeneration, and nuclear BrdU labeling and liver regeneration rate were greatly increased by follistatin. In contrast, administration of activin A attenuated liver regeneration. After 120 h of 90% hepatectomy, histological analysis showed that the hepatic architecture was restored in control and activin-treated rats. However, it was not restored in follistatin-treated rats. The serum bilirubin levels were significantly increased in follistatin-treated rats, and the serum glucose level was significantly lower in follistatin-treated rats. Although follistatin markedly accelerated liver regeneration, it reduced the function of the remnant liver. Treatment with activin A instead may be beneficial to support liver regeneration after massive hepatectomy.
ACTIVINS, multifunctional cytokines expressed in various organs and tissues, are structurally related to transforming growth factor-b (TGF-b) and modulate various cellular functions [1] . During development, activins regulate differentiation of various types of cells and modulate organogenesis [2, 3] . In adults, they act as regulators of tissue repair [4] . Thus, activins inhibit cell growth, promote differentiation and modulate the immune system. They also accelerate production of extracellular matrix proteins and are involved in the pathogenesis of tissue fibrosis.
In the liver, activin A is synthesized predominantly in hepatocytes [5] . It has been shown that under pathological conditions, non-parenchymal cells also produce activin A [6] . Activin A is an autocrine growth inhibitor produced in hepatocytes and tonically inhibits proliferation of hepatocytes [7, 8] . Activin A also induces differentiation of hepatocytes (Zhang YQ and Kojima I, unpublished observation). In addition, this factor also regulates the function of non-parenchymal cells. For example, tubulogenesis of sinusoidal endothelial cells is augmented by activin A [9] , and the collagen production in hepatic stellate cells is stimulated by activin A [10] . This is an important action of activin A because during liver regeneration, reconstruction of hepatic sinusoid is critical for the reorganization of the liver architecture. After partial hepatectomy, the expression of the b A subunit of activin drops abruptly [5, 11] . The expression of the b A then increases gradually at 12 to 24 hrs after hepatectomy and remains elevated until the liver regeneration is terminated. When the action of activin A is neutralized by administration of follistatin, an activin antagonist, liver regeneration after partial hepatectomy is accelerated [7, 8, 12] . Thus, the initiation of DNA replication takes place six hours prior compared to that of the normal situation, and the number of proliferating hepatocytes increases considerably. Consequently, the remnant liver weight and liver regeneration rate are greater in follistatin-treated rats. Follistatin is quite effective in promoting liver regeneration after partial hepatectomy. Follistatin is particularly effective in 90% hepatectomized rats [12] . When treated with follistatin, DNA synthesis takes place only several hours after hepatectomy, and the number of replicating hepatocytes are considerably greater for several days thereafter. Although follistatin markedly accelerate liver regeneration, there may be some adverse effects. For example, the serum bilirubin concentration is higher in follistatin-treated rats compared to that in control rats. A question therefore arises as to whether or not promotion of liver regeneration by follistatin is actually beneficial under these circumstances. Given that activin A induces differentiation of hepatocytes, acceleration of hepatocyte growth by blocking the activin action may result in malfunction of the remnant liver. To test this possibility, we administered either activin A or follistatin to 90% hepatectomized rats and compared the effects of these factors on the morphology and function of the remnant liver.
Materials and Methods

Ninety percent hepatectomy
Male Wistar rats weighing 150 g were kept in a temperature-controlled and artificially illuminated room. All animals were fasted for 24 h prior to surgery [12] . Ninety percent hepatectomy was performed through a midline incision under diethylether anesthesia as described by Gaub and Iverson [13] . After the hepatectomy, 50 mg of cefazol sodium was administered intraabdominally. After the operation, the animals were given a single 10 ml subcutaneous injection of 5% glucose and received ad libitum 20% glucose solution in tap water for a period of 72 h. No food was offered during this period. After 72 h, all animals were allowed access to regular laboratory chow (Oriental Mouse Food, Tokyo, Japan). Using this protocol, all rats survived after 90% hepatectomy.
Administration of activin A and follistatin
After 90% hepatectomy, the cecum was washed out from the peritoneal cavity and the ileocolic vein was stretched. Three hundred ng of recombinant human follistatin or 100 ng recombinant human activin A [7, 12] dissolved in 0.5 ml of physiological saline was infused into the portal vein via the ileocolic vein. The same volume of saline was infused in control animals.
Measurement of liver regeneration
Changes in the postoperative body weight were measured at indicated time points. Rats were decapitated at various time points and the remnant liver weight was measured. The ratio of the remnant liver weight to the initial body weight was calculated. The liver regeneration rate was calculated according to Fishback [14] by the following equation: Liver Regeneration Rate (%) = 100 × {C -(A -B)}/A, where A is the estimated whole liver weight at operation; B is the excised liver weight; and C is the remnant liver weight at a given time point [8] . The nuclear labeling index was measured by using bromodeoxy uridine (BrdU). At 6, 12, 24, 48, 72 and 120 h after 90% hepatectomy, 20 mg BrdU was injected intraperitoneally. After 30 min, rats were decapitated and the remnant liver was excised and weighed. A transversal slice was obtained from the paracaval portion, and a sagital slice was obtained from the caudate robe, respectively. Slices were fixed with BouinHolland solution. After dehydration and embedding in paraplast, 4 mm-thick sections were cut. The sections were immunostained with anti-BrdU antibody (Amersham, Bucks, UK). Nuclear labeling was measured in five sections per rat, and the average of the determinations was calculated [15, 16] .
Measurement of biochemical parameters in serum
Blood samples were obtained at the time of decapitation, and serum samples were maintained at -20°C until measurement. Albumin, AST, lactate dehydrogenase (LDH), bilirubin, glucose and total chesterol were measured with an automatic analyzer using a kit obtained from Wako Junyaku (Tokyo, Japan).
Statistical analysis
Statistical significance between the groups was assessed by analysis of variance followed by multiple comparison using a modified Student t-test [7] .
Results
Effect of follistatin and activin A on BrdU-labeling in 90% hepatectomized rats As described previously [12] , starvation of rats im-proved the survival rate after 90% hepatectomy. In the present study, we performed 90% hepatectomy in 24-h-starved rats. In control rats, nuclear BrdU labeling was not observed at 6 h of 90% hepatectomy. The first peak of BrdU labeling was observed at 12 h and the labeling disappeared at 24 h of hepatectomy. The second peak was observed at 48 h (Fig. 1) . In follistatintreated rats, nuclear BrdU labeling was detected at 6 h of hepatectomy, and the first peak value obtained at 12 h was significantly higher than that in control rats. BrdU labeling was decreased at 24 h but was still significantly higher than that in control rats. Nuclear BrdU labeling in follistatin-treated rats remained elevated thereafter and was significantly higher compared to that in control rats. In activin-treated rats, the pattern of the changes in the nuclear labeling was quite different. BrdU labeling was not detected until 24 h after hepatectomy. There was no peak of BrdU labeling and BrdU-labeling nuclei increased gradually. The total number of labeled nuclei was considerably lower in activin-treated rats (Fig. 1B) .
Effect of follistatin and activin A on liver regeneration rate in 90% hepatectomized rats
In control rats, the liver regeneration rate increased linearly as a function of time. In follistatin-treated rats, the liver regeneration rate was significantly higher at 48 h of hepatectomy than that in control rats. At later time points, follistatin-treated rats demonstrated a higher liver regeneration rate. In sharp contrast, the liver regeneration rate was significantly lower in rats treated with activin A at 48 h or later. Fig. 3 depicts the histology of the remnant liver 120 h after 90% hepatectomy. At this time point, the sinusoidal structure of the liver was mostly reorganized, and the hepatic cord structure was observed in control rats (Fig. 3A) . In sharp contrast, sinusoidal structure was not yet established in follistatin-treated remnant liver and hepatocytes distributed randomly. Vacuoles were observed in hepatocytes, and the hepatic cord was not significant at this point (Fig. 3B) . In activin-treated rats, the sinusoidal structure was reorganized, and the hepatic cord was clearly observed (Fig. 3C) .
Effect of follistatin and activin A on histology of the remnant liver
Effect of follistatin and activin A on biochemical parameters
Following 90% hepatectomy, an increase in the serum bilirubin level was observed in control rats. The serum bilirubin level peaked at 24 h and then decreased gradually (Fig. 4A) . In follistatin-treated rats, the serum bilirubin levels were much higher than those in control rats. The bilirubin concentration peaked at 48 h and the peak value was three times higher than that in control rats. In contrast, the serum bilirubin levels were lower in activin-treated rats.
In control rats, the serum glucose concentration was slightly higher after 90% hepatectomy (Fig. 4B) . In follistatin-treated rats, the serum glucose levels were significantly lower at 24 and 48 h of hepatectomy compared to those in control rats. In contrast, the serum glucose levels were not changed in activin-treated rats. Changes in the other biochemical parameters are shown in Table 1 . Fig. 3 . Histology of the liver after 90% hepatectomy Live specimens were obtained 120 h after hepatectomy from control (A), follistatin-treated (B) and activintreated (C) rats. HE staining was performed. 
Discussion
In the present study, we compared the effects of administration of follistatin and activin A on liver regeneration in 90% hepatectomized rats. In agreement with our previous work [12] , administration of follistatin markedly accelerated regeneration after 90% hepatectomy. Thus, BrdU nuclear labeling started more than 6 hours earlier compared to that for control rats, and the total number of BrdU-labeled nuclei was more than twice the number compared to that in follistatintreated control rats. Consequently, liver regeneration rates were significantly higher than those in control rats. Conversely, administration of activin A considerably attenuated liver regeneration after 90% hepatectomy. Thus, the onset of DNA replication was delayed at last 12 hours in activin-treated rats. No peak of BrdUlabeling was observed, the total number of BrdUlabeling nuclei was lower and the liver regeneration rate was significantly lower compared to that in control rats. In terms of increment of DNA replication and remnant liver weight, follistatin treatment was extremely effective and activin A treatment had an opposite effect.
With regard to remnant liver function, however, assessment of the effect of follistatin may be quite different. Although follistatin accelerated regeneration quite effectively, serum bilirubin concentration during the period was significantly higher. Either metabolism or excretion of bilirubin was impaired during the period.
Likewise, serum glucose concentration was significantly lower in follistatin-treated rats. This was probably due to reduction of glucose production in the liver. Presumably, because proliferation of hepatocytes was quite active in this period, glucose production may have been attenuated. Since we used starved rats in our experiment, it was gluconeogenesis that was impaired in follistatin-treated rats. Augmentation of hepatocyte proliferation may result in reduction of mature function of hepatocytes. In this sense, excessive proliferation induced by follistatin may not be advantageous. It should be noted that administration of follistatin did not reduce the serum glucose concentration in 70% hepatectomized rats [7] . Accordingly, acceleration of hepatocyte growth did not cause hypoglycemia in this condition. Presumably, the mass of the remnant liver is critical and we need to be careful to promote hepatocyte proliferation after massive hepatectomy.
Histological examination supported this notion. In follistatin-treated liver, the mature architecture of the liver was not reconstructed at 120 h after 90% hepatectomy. In contrast, the hepatic cord structure was reorganized in control and activin-treated rats. Again, augmentation of hepatocyte proliferation by follistatin was not beneficial in terms of reorganization of the liver architecture.
It should be mentioned that 90% hepatectomy is an extreme animal model of liver regeneration. However, results obtained in this model may have implications for the treatment of liver failure in various disorders in humans. In particular, extreme stimulation of hepatocyte replication instead deteriorated the liver function. Activin-treatment slowed down hepatocyte proliferation and thereby regeneration occurred gradually. Nevertheless, remnant liver function was better and liver architecture was restored. This was perhaps due to the differentiation-inducing activity of activin A. Hence, appropriate growth inhibition together with possible induction of differentiation is beneficial to support liver regeneration after massive hepatectomy.
